文献速递主动脉疾病

腹主动脉瘤腔内修复术前预防性栓塞侧支预防2型内漏后瘤囊缩小长达2年:回顾性单中心研究

Abdominal Aortic Aneurysm Shrinkage up to 2 Years Following Endovascular Repair with PEmbolization for Preventing Type 2 Endoleak: A Retrospective Single Center Study.
PubMed 文献 · Ann Vasc Surg · 2022-07-08

本研究回顾性纳入200例腹主动脉瘤患者,比较预防性栓塞(97例)与非栓塞(103例)两组。栓塞组成功栓塞89%的通畅侧支。EVAR后2年内,栓塞组瘤囊缩小率73% vs 42%(P<0.0001),瘤囊增大0% vs 5%(P<0.05),2型内漏相关再干预风险比为0.11(95%CI 0.0061-0.60,P<0.01)。两组全因死亡、动脉瘤相关死亡及并发症无显著差异。

要点

  • 预防性栓塞组2年内瘤囊缩小率73%,非栓塞组42%(P<0.0001)。
  • 栓塞组2型内漏相关再干预风险比为0.11(95%CI 0.0061-0.60,P<0.01)。
  • 两组全因死亡、动脉瘤相关死亡及并发症无显著差异。

核心结论

  • 预防性栓塞动脉瘤侧支成功率高,栓塞组EVAR后2年内瘤囊解剖改变更优且2型内漏相关再干预率更低。

研究设计与样本

  • 回顾性单中心研究,纳入2009年4月至2019年4月在本机构连续接受EVAR的患者200例,分为非栓塞组(2009年4月至2014年5月,N=103)和栓塞组(2014年4月至2019年4月,N=97)。

主要发现

  • 栓塞组成功栓塞所有通畅动脉瘤侧支的89%。
  • EVAR后2年内,栓塞组瘤囊缩小(≥5 mm)率73% vs 非栓塞组42%(P<0.0001)。
  • 栓塞组瘤囊增大(≥5 mm)率0% vs 非栓塞组5%(P<0.05)。
  • 栓塞组2型内漏相关再干预风险比为0.11(95%CI 0.0061-0.60,P<0.01)。
  • 两组全因死亡、动脉瘤相关死亡及并发症无显著差异。

关键数值与推荐

  • 瘤囊缩小定义为≥5 mm,瘤囊增大定义为≥5 mm。
  • 两组基线特征相似,除高血压、通畅腰动脉及Zenith、Excluder和Endurant支架的使用外。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of the present study was to evaluate the efficacy of preemptive embolization of aneurysm side branches that cause type 2 endoleak (T2EL). METHODS: We performed a retrospective review of consecutive patients who underwent endovascular aneurysm repair (EVAR) in our facility between April 2009 and April 2019. All the patients underwent the preemptive embolization for preventing T2EL since April 2014. The patients were divided into the nonembolization group (between April 2009 and May 2014) or the embolization group (between April 2014 and April 2019). We used a support wire to improve a success rate of the preemptive embolization. The aneurysm sac shrinkage (≧5 mm), freedom from all-cause death and aneurysm-related death, T2EL-related reinterventions, aneurysm sac enlargement (≧5 mm), and complications related to the endovascular procedure were compared between the 2 groups. RESULTS: Two-hundred patients with abdominal aortic aneurysm were included. They were divided into the nonembolization group (N = 103) and the embolization group (N = 97). We successfully embolized 89% of all the patent aneurysm side branches in the embolization group. The characteristics of the 2 groups were similar except for hypertension, patent lumbar arteries, and the use of Zenith, Excluder, and Endurant. The preemptive embolization group showed better aneurysm sac shrinkage (73% vs. 42%; P < 0.0001), no aneurysm sac enlargement (0% vs. 5%; P < 0.05), and lower T2EL-related reintervention rate (hazard ratio, 0.11; 95% confidence interval, 0.0061-0.60; P < 0.01) up to 2 years after EVAR. There were no significant differences in freedom from all-cause death, aneurysm-related death, and complications between the 2 groups. CONCLUSIONS: The present study showed the high success rate of preemptive embolization of aneurysm side branches resulting in better anatomical changes in the aneurysm sac and lower T2EL-related intervention rate in the embolization group up to 2 years after EVAR.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Nakayama H, Toma M, Kobayashi T, et al. Abdominal Aortic Aneurysm Shrinkage up to 2 Years Following Endovascular Repair with PEmbolization for Preventing Type 2 Endoleak: A Retrospective Single Center Study. Ann Vasc Surg. 2022. PMID: 35810944. doi:10.1016/j.avsg.2022.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。